X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.640
0.00 (0.00%)
Nov 28, 2025, 1:00 PM EST - Market closed
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $318.27 million as of November 28, 2025. Its market cap has increased by 219.01% in one year.
Market Cap
318.27M
Enterprise Value
273.43M
1-Year Change
219.01%
Ranking
Category
Stock Price
$3.64
Market Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has increased from $101.77M to $318.27M, an increase of 212.73%. That is a compound annual growth rate of 18.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 318.27M | 154.39% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | 104.72M | -39.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.22B |
| Johnson & Johnson | 495.06B |
| AbbVie | 400.98B |
| UnitedHealth Group | 300.39B |
| AstraZeneca | 287.99B |
| Merck & Co. | 259.50B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 224.85B |